Moderna is on a mission to deliver transformative mRNA medicines that improve lives. To achieve this ambitious goal, the biotech pioneer is leaving no stone unturned – including leveraging the power of artificial intelligence. In 2023, Moderna began partnering with OpenAI to integrate generative AI across key functions. This collaboration marks a turning point for both companies in working together to advance human health.
Table of Contents
Moderna Adoption of AI
Moderna adopted AI with careful planning to ensure widespread adoption and benefits. Their goal was 100% proficiency in generative AI among relevant teams within six months. A dedicated transformation team led individual and collective change initiatives. Training programs educated employees on AI capabilities through various formats. “Top 100” AI users were identified and formed a champion cohort to drive peer learning.
Additionally, its culture of curiosity supported local learning hubs and discussion forums. Weekly AI topic participation grew to over 2000 employees. Leadership involvement through town halls signaled AI’s importance.
Moderna mChat Chabot Built with OpenAI API
These efforts led to mChat, an internal chatbot built on OpenAI’s API. With over 80% adoption, mChat established AI familiarity prior to expanding capabilities. Moderna created solid change management groundwork ensuring technological shifts uplift all people. When they tested mChat against Copilot and ChatGPT Enterprise, the latter far exceeded expectations.
Moderna Widespread Adoption of ChatGPT Enterprise
Moderna witnessed widespread usage within a short period of adopting ChatGPT Enterprise across all teams and functions. It has provided its 3,000 employees with access to a special version of ChatGPT Enterprise, built on GPT-4, to automate various business processes. Interestingly, Moderna has gone beyond just using the base model. They’ve created over 750 specialized versions of GPTs tailored to address specific tasks across the company. These GPT applications range from optimizing drug trial dosages to generating responses for regulatory inquiries, significantly speeding up processes.
Moderna Dose ID GPT
One of the most notable uses of ChatGPT Enterprise is in clinical trials. Moderna’s “Dose ID” GPT reviews large datasets and helps determine the optimal vaccine dosage. It provides visualizations and rationale to aid complex decision-making. This helps Moderna’s rigorous evaluation and selection of doses for late-stage testing. Moreover, the AI assistant boosts analytical capabilities without compromising safety and privacy.
ChatGPT Enterprise Streamlines Compliance and Outreach
Custom GPTs summarize contracts, prepare presentations and translate complex terms for different audiences. Additionally, Moderna’s legal and branding divisions leverage ChatGPT Enterprise to streamline processes and tell their story to varied audiences. The AI partner proves instrumental in ensuring policies and protocols are followed.
Together, Moderna And OpenAI Are Redefining Biotech
Through AI-supported processes, Moderna can accomplish what traditionally required 100,000 employees with just thousands. Resources focus on high-impact work rather than low-value tasks.
By streamlining operations, Moderna enhances patient outcomes. “We’re thankful for OpenAI’s partnership in helping save more lives,” says CEO Stéphane Bancel.
This collaboration isn’t only applying new technologies, but pioneering medical R&D models. Where most see limits, Moderna and OpenAI envision expanded possibilities for humanity. Moreover, their vision of collective intelligence through generative AI will continue redefining what’s achievable at the intersection of science, technology and health.
Conclusion
The Moderna and OpenAI partnership exemplifies a future where advanced technologies augment human potential to solve healthcare challenges at unprecedented speed and scale. It is inspiring the medical industry to reimagine what’s possible. Additionally, from research and development to manufacturing and commercial operations, ChatGPT Enterprise is revolutionizing the way Moderna operates and is bringing about transformative solutions.
| Also Read Latest From Us
- Forget Towers: Verizon and AST SpaceMobile Are Launching Cellular Service From Space

- This $1,600 Graphics Card Can Now Run $30,000 AI Models, Thanks to Huawei

- The Global AI Safety Train Leaves the Station: Is the U.S. Already Too Late?

- The AI Breakthrough That Solves Sparse Data: Meet the Interpolating Neural Network

- The AI Advantage: Why Defenders Must Adopt Claude to Secure Digital Infrastructure







